Underlying mechanisms of obesity-induced obstructive sleep apnea
肥胖引起的阻塞性睡眠呼吸暂停的潜在机制
基本信息
- 批准号:10636633
- 负责人:
- 金额:$ 65.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-06-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AnatomyApneaArousalAutonomic PathwaysBehaviorBody WeightBody Weight decreasedBody fatBreathingCardiovascular systemCatecholaminesClinicalComputer ModelsControl GroupsDataDependenceDilatorDiseaseEpidemicEvaluationExclusionFatty acid glycerol estersFollow-Up StudiesFunctional Residual CapacityFunctional disorderHealthHypercapniaHypoxemiaHypoxiaImageImaging TechniquesImpairmentIndividualInflammatoryLeadLife ExpectancyLinkLiteratureLongterm Follow-upMagnetic Resonance ImagingMechanicsMedicalMorbid ObesityMuscleNeurocognitiveObesityObstructive Sleep ApneaOperative Surgical ProceduresOutcomeParticipantPathogenesisPathway interactionsPatientsPatternPersonsPharmaceutical PreparationsPharyngeal structurePopulationPositioning AttributePredictive ValuePrevalencePreventionPublic HealthRecommendationRecurrenceResearchResidual volumeResolutionRiskRisk FactorsRoleSleepSleep Apnea SyndromesStructureTestingTherapeuticThinnessTimeTongueTotal Lung CapacityTractionWakefulnessWeight maintenance regimenWorkbariatric surgerydiet and exerciseexperienceimprovedindividualized medicineinsightlung volumenovel therapeutic interventionobese personpersonalized approachpharyngeal critical pressurepoor health outcomepressureprimary outcomerecruitresponsetrait
项目摘要
Obstructive sleep apnea (OSA) is a highly prevalent disease with major neurocognitive and cardiovascular
sequelae. Obesity is a major risk factor for OSA, but the underlying mechanisms remain unclear. Given the
rising prevalence of obesity and the lack of adequate therapies for some afflicted patients, further mechanistic
work is clearly required. Bariatric surgery is being done increasingly with compelling outcome data emerging;
however, clinical response to weight loss is highly variable. In some patients, OSA is not present at baseline,
despite morbid obesity, in other patients, OSA resolves following bariatric surgery, while other patients have
persistence of OSA despite weight loss, and still other patients can experience re-emergence of OSA in long
term follow-up studies after bariatric surgery. OSA can occur due to several major pathophysiological factors
including pharyngeal anatomy, pharyngeal dilator muscle dysfunction, unstable ventilatory control, end-
expiratory lung volume and arousal threshold. As a result considerable complexity exists in the obesity/OSA
relationship, suggesting the need for further research. First, we will perform a baseline evaluation of
pathophysiological traits among obese people prior to weight loss surgery. Because some people will have
OSA and some will not, we will define the potential mechanisms underlying OSA and potential protective
mechanisms among obese people without OSA (pharyngeal critical closing pressure Pcrit primary outcome).
Second, we will re-evaluate these same individuals from the standpoint of sleep study and pathophysiological
traits six months following bariatric surgery after a variable degree of weight loss. We anticipate that some OSA
patients will have resolution of OSA whereas others will have persistence of disease. For non-OSA patients
undergoing weight loss, we will have a positive control group which will allow us to account for non-specific
effects of weight loss. This aim will allow us to test the hypothesis that pharyngeal mechanics is the predominant
mechanism whereby weight loss leads to improvement in OSA. Third, we will perform magnetic resonance
imaging during wakefulness at functional residual capacity, total lung capacity and residual volume on
participants at baseline and 6months following bariatric surgery. This aim will allow us to perform
structure/function assessments in our participants, to define the impact of weight loss on pharyngeal anatomy,
and to quantify the lung volume dependence of the upper airway before and after weight loss. The acquired
data will also be used for computational modeling including dynamic assessment of pharyngeal function during
tidal breathing. As a result of the proposed research, we are confident that we will gain major insights into the
as yet unanswered question “why does obesity (sometimes) cause sleep apnea”. This research will have major
therapeutic implications as it will allow us to individualize therapy for afflicted patients.
阻塞性睡眠呼吸暂停(OSA)是一种高度普遍的疾病,具有主要的神经认知和心血管
后遗症。肥胖是OSA的主要危险因素,但潜在的机制尚不清楚。鉴于
肥胖症患病率上升和一些患者缺乏足够的疗法,进一步的机理
显然需要工作。随着引人注目的结果数据的出现,减肥手术正在越来越多地进行;
但是,对减肥的临床反应是高度可变的。在某些患者中,OSA在基线时不存在,
尽管病态肥胖症,但在其他患者中,软骨手术后仍能解决OSA,而其他患者则具有
OSA目的地减肥的持久性,还有其他患者可以长期体验OSA的重新出现
减肥手术后的术语随访研究。 OSA可能由于几个主要的病理生理因素而发生
包括咽解剖,咽部扩张肌功能障碍,不稳定的通风控制,末端
呼气肺体积和唤醒阈值。结果,肥胖/OSA中存在相当大的复杂性
关系,表明需要进一步研究。首先,我们将对
减肥手术前肥胖者的病理生理特征。因为有些人会
OSA和某些人不会,我们将定义OSA的潜在机制和潜在的保护
没有OSA的肥胖者的机制(咽临界关闭压力PCRIT主要结果)。
其次,我们将从睡眠研究和病理生理学的角度重新评估这些相同的个体
减肥程度可变后,减肥手术后六个月的特征。我们预计会有一些OSA
患者将分辨出OSA,而其他患者将持续存在疾病。对于非OSA患者
减肥,我们将拥有一个阳性对照组,这将使我们能够考虑非特异性
体重减轻的影响。这个目标将使我们能够检验咽部机制是主要主导的假设
体重减轻会导致OSA改善的机制。第三,我们将执行磁共振
在唤醒期间以功能残留能力,总肺容量和剩余体积的成像成像
减肥手术后基线和6个月的参与者。这个目标将使我们能够执行
参与者中的结构/功能评估,以定义减肥对咽解剖学的影响,
并量化体重减轻之前和之后的上呼吸道的肺体积依赖性。获得的
数据还将用于计算建模,包括对咽功能的动态评估
潮汐呼吸。由于拟议的研究,我们有信心我们将获得对
尚未解决的问题“肥胖症(有时)为什么会导致睡眠呼吸暂停”。这项研究将有重大
治疗意义将使我们能够为患者的患者个性化治疗。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Atul Malhotra其他文献
Atul Malhotra的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Atul Malhotra', 18)}}的其他基金
The cardiovascular consequences of sleep apnea plus COPD (Overlap syndrome)
睡眠呼吸暂停加慢性阻塞性肺病(重叠综合征)对心血管的影响
- 批准号:
10733384 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别:
VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19
VentNet:用于预测 COVID-19 患者呼吸衰竭的实时多模式数据集成模型
- 批准号:
10367298 - 财政年份:2022
- 资助金额:
$ 65.17万 - 项目类别:
VentNet: A Real-Time Multimodal Data Integration Model for Prediction of Respiratory Failure in Patients with COVID-19
VentNet:用于预测 COVID-19 患者呼吸衰竭的实时多模式数据集成模型
- 批准号:
10573201 - 财政年份:2022
- 资助金额:
$ 65.17万 - 项目类别:
Sleep Apnea Endophenotypes: One Size Does Not Fit All
睡眠呼吸暂停内表型:一种方法并不适用于所有情况
- 批准号:
10084644 - 财政年份:2021
- 资助金额:
$ 65.17万 - 项目类别:
Sleep Apnea Endophenotypes: One Size Does Not Fit All
睡眠呼吸暂停内表型:一种方法并不适用于所有情况
- 批准号:
10404911 - 财政年份:2021
- 资助金额:
$ 65.17万 - 项目类别:
Sleep Apnea Endophenotypes: One Size Does Not Fit All
睡眠呼吸暂停内表型:一种方法并不适用于所有情况
- 批准号:
10686814 - 财政年份:2021
- 资助金额:
$ 65.17万 - 项目类别:
Underlying mechanisms of obesity-induced obstructive sleep apnea
肥胖引起的阻塞性睡眠呼吸暂停的潜在机制
- 批准号:
10404650 - 财政年份:2020
- 资助金额:
$ 65.17万 - 项目类别:
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease
阻塞性睡眠呼吸暂停对阿尔茨海默病的发展很重要吗
- 批准号:
9974144 - 财政年份:2020
- 资助金额:
$ 65.17万 - 项目类别:
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease
阻塞性睡眠呼吸暂停对阿尔茨海默病的发展很重要吗
- 批准号:
10615709 - 财政年份:2020
- 资助金额:
$ 65.17万 - 项目类别:
Is Obstructive Sleep Apnea Important in the Development of Alzheimer's Disease
阻塞性睡眠呼吸暂停对阿尔茨海默病的发展很重要吗
- 批准号:
10398186 - 财政年份:2020
- 资助金额:
$ 65.17万 - 项目类别:
相似国自然基金
Piezo2在阻塞性睡眠呼吸暂停相关颏舌肌压力调控障碍中的作用及机制研究
- 批准号:82371132
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
阻塞性睡眠呼吸暂停通过对骨髓造血干祖细胞的表观遗传修饰诱导训练免疫促进动脉粥样硬化
- 批准号:82370338
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
儿茶酚胺信号通路对正常体重患者的阻塞性睡眠呼吸暂停相关性高血压的调控机制
- 批准号:82300117
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
阻塞性睡眠呼吸暂停综合征超声心动图左室几何构型异常的分子机制研究
- 批准号:82371989
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
咽腔不同塌陷模式下的压力损失对阻塞性睡眠呼吸暂停低通气综合征负压努力依赖呼吸的调控机制研究
- 批准号:82370090
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Upper airway collapsibility, loop gain and arousal threshold: an integrative therapeutic approach to obstructive sleep apnea
上气道塌陷、循环增益和唤醒阈值:阻塞性睡眠呼吸暂停的综合治疗方法
- 批准号:
10859275 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别:
Towards personalized medicine: pathophysiologic contributions to post-stroke sleep apnea
迈向个性化医疗:中风后睡眠呼吸暂停的病理生理学贡献
- 批准号:
10654941 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别:
Adipose Dysfunction, Imaging, Physiology, and Outcomes with SGLT2i's for Sleep Apnea: The ADIPOSA Study
脂肪功能障碍、影像学、生理学和 SGLT2i 治疗睡眠呼吸暂停的结果:ADIPOSA 研究
- 批准号:
10583864 - 财政年份:2023
- 资助金额:
$ 65.17万 - 项目类别:
Upper airway collapsibility, loop gain and arousal threshold: an integrative therapeutic approach to obstructive sleep apnea
上气道塌陷、循环增益和唤醒阈值:阻塞性睡眠呼吸暂停的综合治疗方法
- 批准号:
10516957 - 财政年份:2022
- 资助金额:
$ 65.17万 - 项目类别:
Randomized Control Trial of oxygen therapy in Children and Adolescents with Down Syndrome and Obstructive Sleep Apnea
唐氏综合症和阻塞性睡眠呼吸暂停儿童和青少年氧疗的随机对照试验
- 批准号:
10518497 - 财政年份:2022
- 资助金额:
$ 65.17万 - 项目类别: